HK1247956A1 - 用於檢測和治療革蘭陽性細菌的鏈球菌噬菌體溶素 - Google Patents

用於檢測和治療革蘭陽性細菌的鏈球菌噬菌體溶素

Info

Publication number
HK1247956A1
HK1247956A1 HK18107229.8A HK18107229A HK1247956A1 HK 1247956 A1 HK1247956 A1 HK 1247956A1 HK 18107229 A HK18107229 A HK 18107229A HK 1247956 A1 HK1247956 A1 HK 1247956A1
Authority
HK
Hong Kong
Prior art keywords
detection
treatment
positive bacteria
gram positive
bacteriophage lysins
Prior art date
Application number
HK18107229.8A
Other languages
English (en)
Inventor
Vincent A Fischetti
Jonathan Schmitz
Daniel Gilmer
Chad Euler
Original Assignee
Univ Rockefeller
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Rockefeller filed Critical Univ Rockefeller
Publication of HK1247956A1 publication Critical patent/HK1247956A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2462—Lysozyme (3.2.1.17)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/50—Hydrolases (3) acting on carbon-nitrogen bonds, other than peptide bonds (3.5), e.g. asparaginase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01017—Lysozyme (3.2.1.17)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HK18107229.8A 2011-04-21 2018-06-01 用於檢測和治療革蘭陽性細菌的鏈球菌噬菌體溶素 HK1247956A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161477836P 2011-04-21 2011-04-21

Publications (1)

Publication Number Publication Date
HK1247956A1 true HK1247956A1 (zh) 2018-10-05

Family

ID=47042182

Family Applications (2)

Application Number Title Priority Date Filing Date
HK18103869.2A HK1244503A1 (zh) 2011-04-21 2018-03-20 用於革蘭氏陽性菌檢測和治療的鏈球菌屬細菌噬菌體溶素
HK18107229.8A HK1247956A1 (zh) 2011-04-21 2018-06-01 用於檢測和治療革蘭陽性細菌的鏈球菌噬菌體溶素

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK18103869.2A HK1244503A1 (zh) 2011-04-21 2018-03-20 用於革蘭氏陽性菌檢測和治療的鏈球菌屬細菌噬菌體溶素

Country Status (12)

Country Link
US (7) US9034322B2 (zh)
EP (2) EP2699253B1 (zh)
JP (4) JP6139509B2 (zh)
CN (4) CN107189997A (zh)
AU (3) AU2012245357B2 (zh)
CA (1) CA2833409A1 (zh)
DK (1) DK2699253T3 (zh)
ES (1) ES2682670T3 (zh)
HK (2) HK1244503A1 (zh)
IL (4) IL228869B (zh)
MX (3) MX336427B (zh)
WO (1) WO2012145630A2 (zh)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2663579T3 (en) 2011-01-14 2017-07-31 Univ California THERAPEUTIC ANTIBODIES AGAINST ROR-1 PROTEIN AND PROCEDURES FOR USE THEREOF
EP2699689A4 (en) * 2011-04-21 2014-12-17 Univ Utrecht Holding Bv LYSINES OF BACTERIOPHAGES OF STREPTOCOCCUS FOR THE TREATMENT OF GRAM POSITIVE BACTERIA IN PET ANIMALS AND IN LIVESTOCK
NL2007038C2 (en) * 2011-07-04 2013-01-07 Vereniging Voor Christelijk Hoger Onderwijs System and method for predicting the viability of a body tissue in a patient, and measuring device used therein.
IL308477A (en) * 2012-05-09 2024-01-01 Contrafect Corp Combinations of bacteriophage lysine and antibiotics against gram-positive bacteria
RU2735103C2 (ru) * 2012-05-09 2020-10-28 Контрафект Корпорейшн Предотвращение, разрушение и обработка биопленки лизином бактериофага
CN104073478A (zh) * 2014-06-13 2014-10-01 上海交通大学 杀灭革兰氏阳性菌的酶抗生素及其制备、用途
GB2543453A (en) 2014-06-26 2017-04-19 Univ Rockefeller Acinetobacter lysins
CN104726439B (zh) * 2015-04-13 2017-11-14 武汉菲吉乐科生物科技有限公司 一种广谱的链球菌裂解酶及其应用
CN104805066B (zh) * 2015-05-18 2018-04-24 武汉菲吉乐科生物科技有限公司 一种葡萄球菌裂解酶及其应用
EP3328417A4 (en) * 2015-07-31 2019-02-06 The Regents of The University of California MYCOBACTERIUM LYSTEASE: A NEW TREATMENT AGAINST ACNE
WO2017044989A1 (en) * 2015-09-13 2017-03-16 The Rockefeller University Clostridium difficile BACTERIOPHAGE LYSINS FOR DETECTION AND TREATMENT OF Clostridium difficile BACTERIA INFECTION
AU2016324307B2 (en) 2015-09-17 2021-10-21 Contrafect Corporation Use of lysin to restore/augment antibacterial activity in the presence of pulmonary surfactant of antibiotics inhibited thereby
DK3454888T3 (da) 2016-05-12 2021-04-26 Contrafect Corp Bouillon-mikrofortyndingsfremgangsmåde til evaluering og bestemmelse af minimal inhibitorisk koncentration for antibakterielle polypeptider
EP3651739A4 (en) * 2017-07-10 2021-04-07 Contrafect Corporation BLOOD COMPONENT POTENTIALIZATION OF LYTIC PROTEIN ANTIBACTERIAL ACTIVITY AND RELATED METHODS AND USES
AU2019205388A1 (en) * 2018-01-05 2020-07-23 Azitra Inc Auxotrophic strains of Staphylococcus bacterium
JP2021513865A (ja) * 2018-02-26 2021-06-03 コントラフェクト コーポレイション 修飾ＰｌｙＳｓ２溶解素及びその使用
KR102073086B1 (ko) * 2018-06-04 2020-02-04 (주)인트론바이오테크놀로지 신규한 스트렙토코커스 수이스 박테리오파지 Str-SUP-1 및 이의 스트렙토코커스 수이스 균 증식 억제 용도
KR102073088B1 (ko) * 2018-06-04 2020-02-04 (주)인트론바이오테크놀로지 신규한 스트렙토코커스 수이스 박테리오파지 Str-SUP-2 및 이의 스트렙토코커스 수이스 균 증식 억제 용도
KR102073094B1 (ko) * 2018-06-04 2020-02-04 (주)인트론바이오테크놀로지 신규한 스트렙토코커스 수이스 박테리오파지 Str-SUP-3 및 이의 스트렙토코커스 수이스 균 증식 억제 용도
EP3837348A4 (en) * 2018-08-17 2022-07-27 Becton, Dickinson and Company TESTING FOR ANTIBIOTIC SENSITIVITY USING MICRODROPLET
WO2020077286A1 (en) 2018-10-12 2020-04-16 Quidel Corporation Extraction reagent for use in an assay for detection of group a streptococcus
CA3134154A1 (en) * 2019-03-22 2020-10-01 Contrafect Corporation Method of treating infective endocarditis
KR20210148320A (ko) * 2019-04-05 2021-12-07 콘트라펙트 코포레이션 사람 혈청의 존재하에 슈도모나스 아에루기노사에 대해 살균 활성을 갖는 리신 및 이의 유도체
KR20210151188A (ko) * 2019-04-11 2021-12-13 콘트라펙트 코포레이션 뼈 및 관절 감염증의 치료 및 예방 방법
CA3178761A1 (en) * 2020-05-19 2021-11-25 Raymond Schuch Modified plyss2 lysins and antibiotic combinations for use against gram-positive bacteria
US20220087266A1 (en) * 2020-09-22 2022-03-24 Mars, Incorporated Compositions and methods for controlling mycotoxin production
CN114480299B (zh) * 2020-10-27 2023-08-29 暨南大学 一种蜡样芽胞杆菌噬菌体及其应用
CN112760312B (zh) * 2021-01-20 2022-06-17 华中农业大学 一种裂解革兰氏阳性菌的裂解酶plyssX609及其应用
WO2023049747A1 (en) * 2021-09-22 2023-03-30 Elanco Us Inc. Streptococcus suis lytic enzyme compositions and methods of use thereof
KR20240015755A (ko) * 2022-07-26 2024-02-06 주식회사 인트론바이오테크놀로지 연쇄상구균에 대하여 용균 활성을 갖는 항균단백질
WO2024059184A1 (en) * 2022-09-16 2024-03-21 The Johns Hopkins University Machine learning systems and related aspects for the detection of disease states
CN116640754B (zh) * 2023-07-21 2023-10-10 临沂大学 一种链球菌前噬菌体裂解酶lys224及应用
CN117965624A (zh) * 2023-10-11 2024-05-03 圆因(北京)生物科技有限公司 一种用于编码耐甲氧西林金黄色葡萄球菌内溶素的线性dna、线性rna及其质粒表达载体

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3278378A (en) 1962-04-19 1966-10-11 Schindler Charles Alvin Staphylococcus-derived antibiotic
US3398056A (en) 1964-07-10 1968-08-20 Mead Johnson & Co Process for producing lysostaphin by fermentation
US3594284A (en) 1968-06-04 1971-07-20 Mead Johnson & Co Lysostaphin fermentation with accelerated time cycle
US3654090A (en) 1968-09-24 1972-04-04 Organon Method for the determination of antigens and antibodies
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US4016043A (en) 1975-09-04 1977-04-05 Akzona Incorporated Enzymatic immunological method for the determination of antigens and antibodies
NZ201918A (en) 1981-09-18 1987-04-30 Genentech Inc N-terminal methionyl analogues of bovine growth hormone
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
EP0501523B1 (en) 1983-11-14 1997-04-09 Columbia Laboratories, Inc. Bioadhesive compositions
DE3590766C2 (zh) 1985-03-30 1991-01-10 Marc Genf/Geneve Ch Ballivet
JP2837846B2 (ja) 1986-10-08 1998-12-16 バーンスタイン，デビッド グループａ連鎖球菌抗原を露出させる方法およびグループａ連鎖球菌を同定するための改善された診断試験
US4948580A (en) 1988-12-08 1990-08-14 E. R. Squibb & Sons, Inc. Muco-bioadhesive composition
JPH02258718A (ja) 1989-03-31 1990-10-19 Nippon Kayaku Co Ltd ペースト状基剤及び製剤
US5264563A (en) 1990-08-24 1993-11-23 Ixsys Inc. Process for synthesizing oligonucleotides with random codons
DK0672142T3 (da) 1992-12-04 2001-06-18 Medical Res Council Multivalente og multispecifikke bindingsproteiner samt fremstilling og anvendelse af disse
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US5554380A (en) 1994-08-04 1996-09-10 Kv Pharmaceutical Company Bioadhesive pharmaceutical delivery system
US5863560A (en) 1996-09-11 1999-01-26 Virotex Corporation Compositions and methods for topical application of therapeutic agents
US5942243A (en) 1996-11-12 1999-08-24 Polytherapeutics, Inc. Mucoadhesive compositions for administration of biologically active agents to animal tissue
US6248324B1 (en) 1997-10-31 2001-06-19 Vincent Fischetti Bacterial phage associated lysing enzymes for treating dermatological infections
US5997862A (en) 1997-10-31 1999-12-07 New Horizons Diagnostics Corporation Therapeutic treatment of group A streptococcal infections
US6254866B1 (en) 1997-10-31 2001-07-03 New Horizons Diagnostics Corporation Use of phage associated lytic enzymes for treating bacterial infections of the digestive tract
US6264945B1 (en) 1997-10-31 2001-07-24 Vincent A Fischetti Parenteral use of bacterial phage associated lysing enzymes for the therapeutic treatment of bacterial infections
US20060292135A1 (en) * 1997-10-31 2006-12-28 Lawrence Loomis Use of bacterial phage-associated lysing proteins for preventing and treating bacterial infections in humans, animals and fowl
CN1352567A (zh) * 1999-02-25 2002-06-05 新眼界诊断公司 预防性和治疗性治疗链球菌感染的方法
EP1162994A4 (en) 1999-02-25 2004-12-29 New Horizons Diagnostics Inc COMPOSITION FOR THE PROPHYLACTIC AND THERAPEUTIC TREATMENT OF STREPTOCOCCAL INFECTIONS
US6056955A (en) 1999-09-14 2000-05-02 Fischetti; Vincent Topical treatment of streptococcal infections
EP1501925A4 (en) 2002-05-17 2006-10-25 New Horizons Diagnostics Corp IDENTIFICATION OF A PHAGEN-ASSOCIATED LYTICAL ENZYME FOR THE FAST AND SPECIFIC DETECTION AND BUTTERFLY OF BACILLUS ANTHRACIS
US8326388B2 (en) 2002-10-31 2012-12-04 Toshiba Medical Systems Corporation Method and apparatus for non-invasive measurement of living body characteristics by photoacoustics
US7217791B2 (en) * 2002-11-07 2007-05-15 Synergy America, Inc. Compositions and methods for treating or preventing pneumococcal infection
WO2004104213A2 (en) * 2003-05-15 2004-12-02 The Rockefeller University Nucleic acids and polypeptides of c1 bacteriophage and uses thereof
US7569223B2 (en) 2004-03-22 2009-08-04 The Rockefeller University Phage-associated lytic enzymes for treatment of Streptococcus pneumoniae and related conditions
WO2005089527A2 (en) 2004-03-24 2005-09-29 The Rockefeller University Lytic enzymes and spore surface antigen for detection and treatment of bacillus anthracis bacteria and spores
GB0410220D0 (en) * 2004-05-07 2004-06-09 Kirkham Lea Ann Mutant pneumolysin proteins
US8389469B2 (en) 2005-06-06 2013-03-05 The Rockefeller University Bacteriophage lysins for Bacillus anthracis
US7582291B2 (en) * 2005-06-30 2009-09-01 The Rockefeller University Bacteriophage lysins for Enterococcus faecalis, Enterococcus faecium and other bacteria
DE602006018746D1 (de) * 2005-08-24 2011-01-20 Univ Rockefeller Ply-gbs-lysinmutanten
IE20060488A1 (en) 2006-06-29 2008-01-09 Teagasc Agric Food Dev Authori Recombinant staphylococcal phage lysin as an antibacterial agent
DE102006061002A1 (de) * 2006-12-22 2008-06-26 Profos Ag Verfahren und Mittel zur Anreicherung, Entfernung und zum Nachweis von gram-positiven Bakterien
CA2706600A1 (en) 2007-11-26 2009-06-04 Plant Bioscience Limited Novel polypeptides having endolysin activity and uses thereof
EP2103308A1 (de) * 2008-03-20 2009-09-23 PhytoLine GmbH Verfahren zur Herstellung eines Gemisches von Bakteriophagen und deren Verwendung für die Therapie von Antibiotika-resistenten Staphylococcen
US8840900B2 (en) 2008-07-03 2014-09-23 The Rockefeller University Chimeric bacteriophage lysin with activity against Staphylococci bacteria
US8481289B2 (en) * 2008-07-24 2013-07-09 The United States Of America, As Represented By The Secretary Of Agriculture Triple acting antimicrobials that are refractory to resistance development
GB0815484D0 (en) * 2008-08-26 2008-10-01 Univ Leuven Kath Antibacterial agents
KR101016918B1 (ko) * 2009-01-08 2011-02-25 주식회사 인트론바이오테크놀로지 박테리아 특이적 넓은 항균 활성을 갖는 신규한 리신 단백질
US8951532B2 (en) * 2010-01-25 2015-02-10 Alere Scarborough, Inc. A25 bacteriophage lysin
EP2699689A4 (en) * 2011-04-21 2014-12-17 Univ Utrecht Holding Bv LYSINES OF BACTERIOPHAGES OF STREPTOCOCCUS FOR THE TREATMENT OF GRAM POSITIVE BACTERIA IN PET ANIMALS AND IN LIVESTOCK

Also Published As

Publication number Publication date
IL266476B (en) 2020-01-30
MX2021007008A (es) 2022-06-02
DK2699253T3 (en) 2018-07-16
ES2682670T3 (es) 2018-09-21
EP2699253A2 (en) 2014-02-26
MX370442B (es) 2019-12-13
IL271300B (en) 2021-12-01
NZ713076A (en) 2017-05-26
CA2833409A1 (en) 2012-10-26
US20140072549A1 (en) 2014-03-13
EP2699253A4 (en) 2015-07-01
IL228869A0 (en) 2013-12-31
US11111484B2 (en) 2021-09-07
JP6587655B2 (ja) 2019-10-09
AU2017202728B2 (en) 2019-04-04
JP2014518849A (ja) 2014-08-07
US20220064615A1 (en) 2022-03-03
JP2016147903A (ja) 2016-08-18
JP2017171686A (ja) 2017-09-28
JP6284976B2 (ja) 2018-02-28
AU2012245357B2 (en) 2017-06-08
US9034322B2 (en) 2015-05-19
US20220127590A1 (en) 2022-04-28
US10544407B2 (en) 2020-01-28
HK1244503A1 (zh) 2018-08-10
WO2012145630A3 (en) 2014-05-01
US20230167427A9 (en) 2023-06-01
MX336427B (es) 2016-01-18
JP6139509B2 (ja) 2017-05-31
IL266476A (en) 2019-06-30
CN108578685A (zh) 2018-09-28
NZ616945A (en) 2015-11-27
US20170298334A1 (en) 2017-10-19
AU2019204660A1 (en) 2019-07-18
AU2012245357A1 (en) 2013-11-14
EP2699253B1 (en) 2018-03-28
CN103857410A (zh) 2014-06-11
CN107189997A (zh) 2017-09-22
IL287530A (en) 2021-12-01
JP2019022504A (ja) 2019-02-14
US11155799B2 (en) 2021-10-26
IL228869B (en) 2019-05-30
MX2013012241A (es) 2014-05-07
US9914915B2 (en) 2018-03-13
WO2012145630A2 (en) 2012-10-26
EP3252155A1 (en) 2017-12-06
US20200002694A1 (en) 2020-01-02
AU2019204660B2 (en) 2021-01-28
IL271300A (en) 2020-01-30
NZ731111A (en) 2019-06-28
AU2017202728A1 (en) 2017-05-18
US20150267185A1 (en) 2015-09-24
US20200149025A1 (en) 2020-05-14
JP6735796B2 (ja) 2020-08-05
CN115887627A (zh) 2023-04-04

Similar Documents

Publication Publication Date Title
IL287530A (en) Streptococcus bacteriophage lysins for the detection and treatment of gram-positive bacteria
IL274832A (en) Combinations of bacteriophage lysine and antibiotics against gram-positive bacteria
HK1245890A1 (zh) 用於微生物檢測的方法和系統
EP2874647A4 (en) METHOD FOR DIAGNOSIS AND TREATMENT
EP2699689A4 (en) LYSINES OF BACTERIOPHAGES OF STREPTOCOCCUS FOR THE TREATMENT OF GRAM POSITIVE BACTERIA IN PET ANIMALS AND IN LIVESTOCK
IL265950A (en) Detection and treatment of leprosy
GB201217097D0 (en) Treatment of bacterial infection
HRP20160150T1 (en) Treatment of streptococcal infections
HK1216141A1 (zh) 使用發酵乳桿菌 治療的方法
HUE038336T2 (hu) Módosított gram-pozitív baktériumok és alkalmazásaik
HK1196289A1 (zh) 用於敗血症的治療和/或改善的藥物
EP2710384A4 (en) DIAGNOSIS AND TREATMENT OF COPD
HUE038830T2 (hu) Módosított gram-pozitív baktériumok és alkalmazásaik
GB201201918D0 (en) Methods and devices for diagnosis of serious bacterial infection
GB201420253D0 (en) Culture of bacteriophage
HK1206594A1 (zh) 預防和治療病毒感染的材料和方法
GB201002295D0 (en) Rapid detection of bacteria
EP2574194A4 (en) MACROCYCLIC COMPOUNDS AND METHODS OF TREATMENT
EP2670407A4 (en) TREATMENT OF BACTERIAL INFECTIONS
AU2012902706A0 (en) Prevention and treatment of haematological conditions